Last Updated:

Sudarshan Pharmaceuticals Pvt Ltd loan details

Charges taken from banks & financial institutes

Data last updated:

Amount in (₹)

Sudarshan Pharmaceuticals Pvt Ltd has 6 charges registered with the Registrar of Companies: 3 open charges worth Rs 16.06 Cr and 3 satisfied charges worth Rs 0.90 M. The lender named on its open charges is State Bank Of India. The most recent charge was created on 07 Feb 2024 in favour of State Bank Of India for Rs 3.20 M and is open.

Charges Breakdown by Lending Institutions

  • State Bank Of India : 16.06 Cr

₹1,606.00 lakh

₹9.00 lakh

1

State Bank Of India

Modification

18 Jul 2025

₹1,071.00 lakh

Charge IdLenderAmountCreation DateLast Modification DateSatisfaction DateStatus
90205817 View DetailsState Bank Of India₹ 1.00 04 Jul 2002-08 Nov 2017 Satisfied 100000.0
90208107 View DetailsState Bank Of India₹ 2.00 15 Dec 199704 Jul 200208 Nov 2017 Satisfied 200000.0
90206746 View DetailsState Bank Of India₹ 6.00 12 Aug 198622 Jul 199308 Nov 2017 Satisfied 600000.0
100886018 View DetailsState Bank Of India₹ 32.00 07 Feb 2024-- Open 3200000.0
100509552 View DetailsState Bank Of India₹ 1,071.00 17 Nov 202118 Jul 2025- Open 107100000.0
90205293 View DetailsState Bank Of India₹ 503.00 15 Dec 199727 Dec 2022- Open 50300000.0
Premium access

Charge documents and asset details

The filed charge documents and the assets pledged under each charge are in the company report.

  • Assets and property pledged under each charge
  • Terms and conditions as filed
  • Filed charge documents where available

Verified entity values are shown only after access is granted.

A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.